Data Foundry

Drug recalls 2015

Tamsulosin Hydrochloride Capsules — Class II drug recall D-1253-2015

Terminated recall by Wockhardt Usa Inc., reported 2015-07-29, distributed nationwide. CGMP Deviations: Firm did not adequately investigate customer complaints.

Recall numberD-1253-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmWockhardt Usa Inc., Parsippany, NJ, United States
Recall initiated2015-04-22
Classified2015-07-17
Reported by FDA2015-07-29
Terminated2018-05-09
DistributedNationwide (US)
Quantity407,958 bottles
Reason classescgmp
NDC64679-0516-02, 64679-0516-03
Lot numbersLN10808, LN10896, LN10901, LN10902, LN10903, LN11020, LN11021, LN11055, LN11056, LN11083, LN11084, LN11085, LN11089, LN11109, LN11110, LN11120, LN11121, LN11149, LN11150, LN11186, LN11187, LN11188, LN11206, LN11226, LN11227, LN11233, LN11251, LN11257, LN11262, LN11263, LN11267, LN11274, LN11288, LN11357, LN11370, LN11371, LN11378, LN11384, LN11387, LN11400 and 6 more
Expiration dates2015-04-30, 2015-05-31, 2015-06-30, 2015-07-31, 2015-08-31, 2015-09-30

Product

Tamsulosin Hydrochloride Capsules, USP*, 0.4 mg Capsules, Packaged in A) 100 Count Bottles (NDC: 64679-516-02) and B) 500 Count Bottles (NDC: 64679-516-03), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.

Reason for recall

CGMP Deviations: Firm did not adequately investigate customer complaints.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1253-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.